Остеопороз
Шрифт:
Pilz S., Tomaschitz A., Ritz E., Pieber T.R. (2009) Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 6: 621–630.
Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017–2029.
Recker R., Ensrud K., Diem S. et al. Normal bone histomorphometry and 3D microarchitecture after 10 years alendronate treatment of postmenopausal women // J. Bone Miner. Res. 2004; 19:45.
Recker О.Р., Delmas P.D., Halse J. et al. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res. 2008 Jan; 23(1): 6–16.
Recker О.Р., Weinstein R.S., Chesnut C.H. 3rd, et al. Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporos Int. 2004 Mar. 15(3): 231–7.
Reid I.R., Schooler B.A., Hannan S.F., Ibbertson H.K. (1986) The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med 16: 193–197.
Rodan G., Reszka A., Golub E., Rizzoli R. Bone safety of long-term bisphosphonate treatment // Curr. Med. Res. Opin. 2004; 20(8): 1291–1300.
Russell R.G., Watts N.B., Ebetino F.H., Rogers M.J. Mechanisms of actions of bisphosphonates: similarities and differences and their potential influence on clinical efficacy // Osteoporosis International. 2008. Vol. 19.Р. 733–759.
Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 83: 754–759.
Shaheen N.J. More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med. Apr 23, 2009. 360(17): 1790–1791.
Simon J.A., Lewiecki E.M., Smith M.E. et al. Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, cross-over study // Clin. Ther. 2002. V. 24. P. 1871–1886.
Siris E.S., Oster M.W., Bilezikian J.P. More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med. Apr 23, 2009. 360(17): 1791.
Solomon D.H., Avorn J., Katz J.N., et al. Compliance with osteoporosis medications. Arch Intern Med. 2005. 165: 2414–2419.
Solomon D.H., Patrick A., Brookhart M.A. More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med. Apr 23, 2009. 360(17): 1789–1790.
Sook-Bin W., Hellstein J.W., Kalmar J.R. Systematic review: Bisphosphonates and osteonecrosis of the jaws // Ann Intern Med. 2006. Vol. 144. Р. 753–761.
Sorensen H.T., Christensen S., Mehnert F., Pedersen L., Chapurlat R.D., Cummings S.R., Baron J.A. Use of bisphosphonates among women and risk оf atrial fibrillation and flutter: population based case-control study // BMJ. 2008. Vol. 336. Р. 813–816.
Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25:320–325.
Tishkoff D.X., Nibbelink K.A., Holmberg K.H., Dandu L., Simpson R.U. (2008) Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology. 149: 558–564.
Vаlean S., Petrescu M., Cаtinean A. et al. Pill esophagitis. Rom J Gastroenterol. 2005. 14(2): 159–63.
Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D’Agostino R.B., Wolf M., Vasan R.S. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503–511;!!!Autier P., Gandini S. (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167: 1730–1737.
Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D’Agostino R.B., Wolf M., Vasan R.S. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503–511.
Witham M.D., Nadir M.A., Struthers A.D. (2009) Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27: 1948–1954.
Wysowski D.K. Reports of esophageal cancer with oral bisphosphonate use. N Engl J Med. Jan 1, 2009. 360(1): 89–90.
Xiao Q., Murphy R.A., Houston D.K., Harris T.B., Chow W., Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: The National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med. 2013; 1–8.
Yoneda T., Hagino H., Sugimoto T., Ohta H., Takahashi S., Soen S., Taguchi A., Toyosawa S., Nagata T., Urade M. Bisphosphonaterelated osteonecrosis of the jaw: position paper from the allied task force committee of Japanese society for bone and mineral research, Japan osteoporosis society, Japanese society of periodontology, Japanese society for oral and maxillofacial radiology, and Japanese society of oral and maxillofacial surgeons // J. Bone Miner Metab, published online 24.03.2010 DOI 10.1007/ s00774-010-0162-7.